ProfileGDS4095 / 220193_at
TitleTamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
OrganismHomo sapiens


SRC1 knockdown control tamoxifen untreated tamoxifen untreated GSM709767 GSM709769 GSM709765 GSM709771 GSM709772 GSM709775 GSM709764 GSM709766 GSM709768 GSM709777 GSM709770 GSM709773 GSM709774 GSM709776 41% 42% 45% 43% 46% 42% 43% 41% 44% 43% 40% 40% 38% 42% sort by genotype/variation sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM709767LY2 SRC1-siRNA tamoxifen treated rep12.828641
GSM709769LY2 SRC1-siRNA tamoxifen treated rep32.8590842
GSM709765LY2 SRC1-siRNA untreated rep33.0599645
GSM709771LY2 SRC1-siRNA untreated rep12.9455343
GSM709772LY2 SRC1-siRNA untreated rep23.1240346
GSM709775LY2 SRC1-siRNA untreated rep42.8695542
GSM709764LY2 control-siRNA tamoxifen treated rep22.9575843
GSM709766LY2 control-siRNA tamoxifen treated rep32.8297241
GSM709768LY2 control-siRNA tamoxifen treated rep12.9795844
GSM709777LY2 control-siRNA tamoxifen treated rep42.915743
GSM709770LY2 control-siRNA untreated rep32.7568840
GSM709773LY2 control-siRNA untreated rep12.778140
GSM709774LY2 control-siRNA untreated rep22.6585338
GSM709776LY2 control-siRNA untreated rep42.8996742